Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.52 |
| ▸ | FBP1 | P09467 | 1/20 | 0.48 |
| ▸ | XDH | P47989 | 1/20 | 0.48 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1435786 | 1.00 | ALDH1A1 (0.60) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL5725736 | 0.93 | ALDH1A1 (0.54) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL2558472 | 0.91 | ALDH1A1 (0.50) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL2558475 | 0.91 | ALDH1A1 (0.50) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL1310214 | 0.87 | ALDH1A1 (0.75) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL1310216 | 0.87 | ALDH1A1 (0.75) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| Cinnamaldehyde SCHEMBL28939820 | 0.84 | ALDH1A1 (0.78) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL9970459 | 0.84 | NFE2L2 (0.62) | NFE2L2HSD11B1FBP1TNFRSF1AAPP | |
| SCHEMBL1308775 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KDM4EMAPTTRPA1LMNA | |
| SCHEMBL1308773 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KDM4EMAPTTRPA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| CN-119456012-A | N-doped modified MOFs (metal-organic frameworks) derived core-shell nano-reactor, and preparation method and application thereof | 湖北汽车工业学院 | 2025-02-18 | — | — | CN | claimed |
| CN-118852032-A | Alpha, beta-unsaturated ketone derivative, preparation method and application thereof | 赣南医科大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118859629-A | Water-soluble photosensitive composite dry film and preparation method thereof | 广东泰亚达光电有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-112826812-B | Pharmaceutical composition for treating colon cancer and application thereof | 青岛大学 | 2023-08-25 | — | — | CN | claimed |
| CN-112694392-B | TRPV3 inhibitor and preparation method thereof | 青岛大学 | 2022-11-22 | — | — | CN | claimed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | claimed |
| WO-2021259288-A1 | AGONIST OF DEACETYLASE AND USE THEREOF | 广州中医药大学(广州中医药研究院) | 2021-12-30 | — | — | WO | claimed |
| CN-112826812-A | Pharmaceutical composition for treating colon cancer and application thereof | 青岛大学 | 2021-05-25 | — | — | CN | claimed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | claimed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | claimed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | claimed |
| US-10800790-B2 | Sesquiterpenoid STAT3 inhibitors | UNIVERSITY OF HAWAII (US) | 2020-10-13 | — | — | US | claimed |
| CN-109627492-B | Preparation method and application of antibacterial hydrophobic inorganic-organic hybrid antibacterial agent | 浙江工业大学 | 2020-08-18 | — | — | CN | claimed |
| CN-110563936-A | Self-flame-retardant antibacterial water-based polyester resin and preparation method thereof | 合众（佛山）化工有限公司 | 2019-12-13 | — | — | CN | claimed |
| US-20160137663-A1 | NOVEL SESQUITERPENOID STAT3 INHIBITORS | UNIVERSITY OF HAWAII (US) | 2016-05-19 | — | — | US | claimed |
| WO-2014205416-A1 | NOVEL SESQUITERPENOID STAT3 INHIBITORS | UNIVERSITY OF HAWAII (US) | 2014-12-24 | — | — | WO | claimed |
| EP-1963344-A1 | ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS | UNIVERSITEIT GENT (BE) | 2008-09-03 | — | — | EP | claimed |
| WO-2007071453-A1 | ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS | UNIVERSITEIT GENT (BE) | 2007-06-28 | — | — | WO | claimed |
| CN-119859122-B | Tyrosinase inhibitor and preparation method and application thereof | 杭州师范大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-119386930-B | Noble metal-Ni coexisting supported catalyst prepared based on Ni-MOF metal node partial reduction, preparation method and application | 浙江师范大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-120004889-A | ALK5 kinase inhibitor and preparation method and application thereof | 延边大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-119859122-A | Tyrosinase inhibitor and preparation method and application thereof | 杭州师范大学 | 2025-04-22 | — | — | CN | disclosed |
| WO-2025053103-A1 | RESIN COMPOSITION EXCELLENT IN TRANSPARENCY AND MOLDED ARTICLE THEREOF | 株式会社ヘミセルロース | 2025-03-13 | — | — | WO | disclosed |
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | disclosed |
| CN-119456012-A | N-doped modified MOFs (metal-organic frameworks) derived core-shell nano-reactor, and preparation method and application thereof | 湖北汽车工业学院 | 2025-02-18 | — | — | CN | disclosed |
| CN-119386930-A | Noble metal-Ni coexisting supported catalyst prepared based on Ni-MOF metal node partial reduction, preparation method and application | 浙江师范大学 | 2025-02-07 | — | — | CN | disclosed |
| US-20250034121-A1 | COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS | NANJING IMMUNOPHAGE BIOMEDICAL CO., LTD. (CN) | 2025-01-30 | — | — | US | disclosed |
| CN-118859629-B | Water-soluble photosensitive composite dry film and preparation method thereof | 广东泰亚达光电有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-115151550-B | External nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP 1) modulators and uses thereof | 桑福德·伯纳姆·普雷比医学发现研究所 | 2024-11-22 | — | — | CN | disclosed |
| CN-118930392-A | Aldehyde deoxidization and reduction method | 温州医科大学 | 2024-11-12 | — | — | CN | disclosed |
| CN-118852032-A | Alpha, beta-unsaturated ketone derivative, preparation method and application thereof | 赣南医科大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118859629-A | Water-soluble photosensitive composite dry film and preparation method thereof | 广东泰亚达光电有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-12043602-B2 | Fendiline derivatives | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-23 | — | — | US | disclosed |
| US-20240228797-A1 | LIQUID REPELLENT SLIPPERY SURFACES AND METHODS OF PREPARATION THEREOF | UNIVERSITY OF DURHAM (GB) | 2024-07-11 | — | — | US | disclosed |
| CN-114058369-B | Fluorescent probe based on styryl oxazolone compound and biological application thereof | 中国科学院上海药物研究所 | 2024-07-02 | — | — | CN | disclosed |
| CN-117945820-A | Method for synthesizing alpha, beta-unsaturated aldehyde compound by copper catalysis | 江苏海洋大学 | 2024-04-30 | — | — | CN | disclosed |
| EP-4326071-A1 | LIQUID REPELLENT SLIPPERY SURFACES AND METHODS OF PREPARATION THEREOF | University Of Durham (GB) | 2024-02-28 | — | — | EP | disclosed |
| CN-117430651-A | Nucleoside monophosphate compound and preparation method thereof | 武汉精准智药科技有限公司 | 2024-01-23 | — | — | CN | disclosed |
| US-11851433-B2 | Compounds, compositions and methods | DENALI THERAPEUTICS INC. (US) | 2023-12-26 | — | — | US | disclosed |
| CN-116789594-A | Synthesis method of N-alkylated pyridine-2-ketone derivative | 常州大学 | 2023-09-22 | — | — | CN | disclosed |
| EP-3625234-B1 | HEXAHYDROPYRAZOLO [1,2-A] DIAZEPINONES AND RELATED HETEROCYCLES AS INHIBITORS OF RIP-1 KINASE | DENALI THERAPEUTICS INC (US) | 2023-09-20 | — | — | EP | disclosed |
| US-20230279246-A1 | MOLECULE-CONTAINING SURFACES AND METHODS OF PREPARATION THEREOF | UNIVERSITY OF DURHAM (GB) | 2023-09-07 | — | — | US | disclosed |
| CN-112826812-B | Pharmaceutical composition for treating colon cancer and application thereof | 青岛大学 | 2023-08-25 | — | — | CN | disclosed |
| EP-4192244-A1 | MOLECULE-CONTAINING SURFACES AND METHODS OF PREPARATION THEREOF | University of Durham (GB) | 2023-06-14 | — | — | EP | disclosed |
| CN-114436767-B | Method for preparing alcohol compound based on zinc acetate catalytic carbonyl reduction | 延安大学 | 2023-05-26 | — | — | CN | disclosed |
| US-20230121698-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute | 2023-04-20 | — | — | US | disclosed |
| WO-2022248877-A1 | LIQUID REPELLENT SLIPPERY SURFACES AND METHODS OF PREPARATION THEREOF | UNIVERSITY OF DURHAM (GB) | 2022-12-01 | — | — | WO | disclosed |
| CN-112694392-B | TRPV3 inhibitor and preparation method thereof | 青岛大学 | 2022-11-22 | — | — | CN | disclosed |
| EP-4081528-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2022-11-02 | — | — | EP | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-115151550-A | Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP 1) modulators and uses thereof | 桑福德·伯纳姆·普雷比医学发现研究所 | 2022-10-04 | — | — | CN | disclosed |
| US-20220177440-A1 | Fendiline Derivatives | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2022-06-09 | — | — | US | disclosed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114436767-A | Method for preparing alcohol compound based on carbonyl reduction catalyzed by zinc acetate | 延安大学 | 2022-05-06 | — | — | CN | disclosed |
| CN-109851570-B | Chalcone derivative containing 1,2, 4-triazine, preparation method and application thereof | 贵州大学 | 2022-04-19 | — | — | CN | disclosed |
| CN-110002952-B | Preparation method of alpha, beta-unsaturated alcohol and/or alpha, beta-saturated alcohol | 赣南医学院 | 2022-03-15 | — | — | CN | disclosed |
| CN-114058369-A | Fluorescent probe based on styrene oxazolone compound and biological application thereof | 中国科学院上海药物研究所 | 2022-02-18 | — | — | CN | disclosed |
| WO-2022029432-A1 | MOLECULE-CONTAINING SURFACES AND METHODS OF PREPARATION THEREOF | UNIVERSITY OF DURHAM (GB) | 2022-02-10 | — | — | WO | disclosed |
| US-20220024938-A1 | Compounds, Compositions and Methods | DENALI THERAPEUTICS INC. (US) | 2022-01-27 | — | — | US | disclosed |
| WO-2021259288-A1 | AGONIST OF DEACETYLASE AND USE THEREOF | 广州中医药大学(广州中医药研究院) | 2021-12-30 | — | — | WO | disclosed |
| US-11174262-B2 | Compounds, compositions and methods | DENALI THERAPEUTICS INC. (US) | 2021-11-16 | — | — | US | disclosed |
| CN-113384566-A | Application of cinnamaldehyde and derivatives thereof as histone deacetylase agonists | 广州中医药大学(广州中医药研究院) | 2021-09-14 | — | — | CN | disclosed |
| CN-107827852-B | Patchoulenone derivative and preparation method and application thereof | 成都中医药大学 | 2021-08-20 | — | — | CN | disclosed |
| CN-113135816-A | Method for synthesizing photoactive bromohydrin compound | 常州大学 | 2021-07-20 | — | — | CN | disclosed |
| WO-2021133915-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2021-07-01 | — | — | WO | disclosed |
| CN-112826812-A | Pharmaceutical composition for treating colon cancer and application thereof | 青岛大学 | 2021-05-25 | — | — | CN | disclosed |
| CN-112694392-A | TRPV3 inhibitor and preparation method thereof | 青岛大学 | 2021-04-23 | — | — | CN | disclosed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | disclosed |
| US-20210070756-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | ABBVIE INC (US) | 2021-03-11 | — | — | US | disclosed |
| CN-108558851-B | Coumarin-oxazole-ethylene type alpha-glucosidase inhibitor and preparation method and application thereof | 贵州医科大学 | 2021-03-05 | — | — | CN | disclosed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | disclosed |
| CN-110746253-B | Synthesis method of beta, beta-disubstituted propionate derivative | 南京工业大学 | 2021-02-05 | — | — | CN | disclosed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | disclosed |
| CN-111840261-A | Deacetylase agonist and application thereof | 广州中医药大学(广州中医药研究院) | 2020-10-30 | — | — | CN | disclosed |
| CN-111840261-A | Deacetylase agonist and application thereof | 广州中医药大学(广州中医药研究院) | 2020-10-30 | — | — | CN | disclosed |
| US-10800790-B2 | Sesquiterpenoid STAT3 inhibitors | UNIVERSITY OF HAWAII (US) | 2020-10-13 | — | — | US | disclosed |
| EP-3164386-B1 | PIPERIDINONE HERBICIDES | FMC CORP (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200291027-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | ABBVIE INC (US) | 2020-09-17 | — | — | US | disclosed |
| CN-110002987-B | Phenylallylidene cyclohexenone derivative, preparation method and application thereof | 南通大学 | 2020-09-15 | — | — | CN | disclosed |
| EP-3313837-B1 | CARBOLINE ANTIPARASITICS | ZOETIS SERVICES LLC (US) | 2020-09-09 | — | — | EP | disclosed |
| CN-109627492-B | Preparation method and application of antibacterial hydrophobic inorganic-organic hybrid antibacterial agent | 浙江工业大学 | 2020-08-18 | — | — | CN | disclosed |
| CN-111499657-A | Synthetic method of isoquinoline oxazolidine | 蚌埠学院 | 2020-08-07 | — | — | CN | disclosed |
| US-10709692-B2 | Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1) | DENALI THERAPEUTICS INC. (US) | 2020-07-14 | — | — | US | disclosed |
| CN-107778256-B | Method for synthesizing quinazolinone from anthranilamide and unsaturated aldehyde | 南京理工大学 | 2020-06-19 | — | — | CN | disclosed |
| EP-3625234-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | Denali Therapeutics Inc. (US) | 2020-03-25 | — | — | EP | disclosed |
| CN-110914275-A | Compounds, compositions and methods | 戴纳立制药公司 | 2020-03-24 | — | — | CN | disclosed |
| US-20200079784-A1 | Compounds, Compositions and Methods | DENALI THERAPEUTICS INC. (US) | 2020-03-12 | — | — | US | disclosed |
| US-10570129-B2 | Carboline antiparasitics | ZOETIS SERVICES LLC (US) | 2020-02-25 | — | — | US | disclosed |
| CN-110746253-A | Synthesis method of β -disubstituted propionate derivative | 南京工业大学 | 2020-02-04 | — | — | CN | disclosed |
| WO-2020021735-A1 | RESIN-COATED METALLIC PIGMENT | DIC株式会社 | 2020-01-30 | — | — | WO | disclosed |
| US-20200031822-A1 | CARBOLINE ANTIPARASITICS | ZOETIS SERVICES LLC (US) | 2020-01-30 | — | — | US | disclosed |
| CN-110563936-A | Self-flame-retardant antibacterial water-based polyester resin and preparation method thereof | 合众（佛山）化工有限公司 | 2019-12-13 | — | — | CN | disclosed |
| US-20190337956-A1 | NEUROACTIVE COMPOUNDS AND METHODS OF USING SAME | The General Hospita Corporation (US) | 2019-11-07 | — | — | US | disclosed |
| US-20190315691-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE | Piramal Enterprises Limited (IN) | 2019-10-17 | — | — | US | disclosed |
| EP-3539962-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | AbbVie Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| US-10301318-B2 | Neuroactive compounds and methods of using the same | THE GENERAL HOSPITAL CORPORATION (US) | 2019-05-28 | — | — | US | disclosed |
| EP-2970330-B1 | TETRACYCLIC BROMODOMAIN INHIBITORS | ABBVIE INC (US) | 2019-04-17 | — | — | EP | disclosed |
| US-20180353480-A1 | ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK1) | APTUIT (VERONA) S.R.L. (IT) | 2018-12-13 | — | — | US | disclosed |
| WO-2018213634-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | DENALI THERAPEUTICS INC. (US) | 2018-11-22 | — | — | WO | disclosed |
| US-20180298003-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | ABBVIE INC (US) | 2018-10-18 | — | — | US | disclosed |
| US-10035800-B2 | Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors | ABBVIE INC. (US) | 2018-07-31 | — | — | US | disclosed |
| EP-3344602-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE | Piramal Enterprises Limited (IN) | 2018-07-11 | — | — | EP | disclosed |
| EP-3313837-A1 | CARBOLINE ANTIPARASITICS | Zoetis Services LLC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-9944602-B2 | Piperidinone herbicides | FMC CORPORATION | 2018-04-17 | — | — | US | disclosed |
| US-9776979-B2 | EBI2 modulators | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2017-10-03 | — | — | US | disclosed |
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-20170247383-A1 | NEUROACTIVE COMPOUNDS AND METHODS OF USING THE SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2017-08-31 | — | — | US | disclosed |
| US-9718840-B2 | Condensed 5-oxazolidinone derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-08-01 | — | — | US | disclosed |
| WO-2017096301-A1 | ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK 1) | DENALI THERAPEUTICS INC. (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20170158638-A1 | PIPERIDINONE HERBICIDES | FMC CORPORATION | 2017-06-08 | — | — | US | disclosed |
| EP-3164386-A1 | PIPERIDINONE HERBICIDES | E. I. du Pont de Nemours and Company (US) | 2017-05-10 | — | — | EP | disclosed |
| WO-2017037662-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE | Piramal Enterprises Limited (IN) | 2017-03-09 | — | — | WO | disclosed |
| US-20170022218-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-01-26 | — | — | US | disclosed |
| WO-2016209635-A1 | CARBOLINE ANTIPARASITICS | ZOETIS SERVICES LLC (US) | 2016-12-29 | — | — | WO | disclosed |
| EP-3095786-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2016-11-23 | — | — | EP | disclosed |
| EP-3087072-A2 | SPIROINDOLINE ANTIPARASITIC DERIVATIVES | Zoetis Services LLC (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20160296499-A1 | Spiroindoline Antiparasitic Derivatives | ZOETIS SERVICES LLC | 2016-10-13 | — | — | US | disclosed |
| US-20160214951-A1 | EBI2 MODULATORS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE | 2016-07-28 | — | — | US | disclosed |
| CN-105777970-A | Preparation method of adsorbent for refining trimesic acid | 张玲 | 2016-07-20 | — | — | CN | disclosed |
| US-20160137663-A1 | NOVEL SESQUITERPENOID STAT3 INHIBITORS | UNIVERSITY OF HAWAII (US) | 2016-05-19 | — | — | US | disclosed |
| US-9290427-B2 | Anti-invasive compounds | UNIVERSITEIT GENT (BE) | 2016-03-22 | — | — | US | disclosed |
| WO-2016003997-A1 | PIPERIDINONE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-01-07 | — | — | WO | disclosed |
| WO-2015200674-A1 | NEUROACTIVE COMPOUNDS AND METHODS OF USING THE SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2015-12-30 | — | — | WO | disclosed |
| US-20150210640-A1 | 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2015-07-30 | — | — | US | disclosed |
| WO-2015100232-A2 | SPIROINDOLINE ANTIPARASITIC DERIVATIVES | ZOETIS SERVICES LLC (US) | 2015-07-02 | — | — | WO | disclosed |
| EP-2876105-A1 | 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2015-05-27 | — | — | EP | disclosed |
| WO-2015048570-A2 | EBI2 MODULATORS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2015-04-02 | — | — | WO | disclosed |
| US-20150011620-A1 | ANTI-INVASIVE COMPOUNDS | UNIVERSITEIT GENT (BE) | 2015-01-08 | — | — | US | disclosed |
| WO-2014205416-A1 | NOVEL SESQUITERPENOID STAT3 INHIBITORS | UNIVERSITY OF HAWAII (US) | 2014-12-24 | — | — | WO | disclosed |
| CN-103006647-B | Use of 3-amido-2-pyridone derivative | UNIV CHINA PHARMA | 2014-09-10 | — | — | CN | disclosed |
| CN-103006647-A | Use of 3-amido-2-pyridone derivative | UNIV CHINA PHARMA | 2013-04-03 | — | — | CN | disclosed |
| EP-1898908-B1 | NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICAMENT | TROPHOS (FR) | 2011-03-30 | — | — | EP | disclosed |
| US-7638505-B2 | Organophosphoric derivatives useful as anti-parasitic agents | UNIVERSITEIT GENT (BE) | 2009-12-29 | — | — | US | disclosed |
| US-20090203747-A1 | NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE | TROPHOS PARC SCIENTIFIQUE LUMINY (FR) | 2009-08-13 | — | — | US | disclosed |
| US-20080312190-A1 | Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents | UNIVERSITEIT GENT (BE) | 2008-12-18 | — | — | US | disclosed |
| US-7449477-B2 | 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B) | ELI LILLY AND COMPANY (US) | 2008-11-11 | — | — | US | disclosed |
| EP-1963344-A1 | ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS | UNIVERSITEIT GENT (BE) | 2008-09-03 | — | — | EP | disclosed |
| EP-1898908-A2 | NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICAMENT | Trophos (FR) | 2008-03-19 | — | — | EP | disclosed |
| WO-2007071453-A1 | ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS | UNIVERSITEIT GENT (BE) | 2007-06-28 | — | — | WO | disclosed |
| US-20070037796-A1 | e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms | ELI LILLY AND COMPANY | 2007-02-15 | — | — | US | disclosed |
| WO-2007003767-A2 | NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE | TROPHOS (FR) | 2007-01-11 | — | — | WO | disclosed |
| CN-1294129-C | Heteraryl-substituted porrole derivatives, their prep. and therapeutic use | SANKYO CO (JP) | 2007-01-10 | — | — | CN | disclosed |
| US-7122666-B2 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 2006-10-17 | — | — | US | disclosed |
| CN-1274655-C | Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same | SERVIER LAB (FR) | 2006-09-13 | — | — | CN | disclosed |
| US-20060128756-A1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 2006-06-15 | — | — | US | disclosed |
| US-20050283006-A1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 2005-12-22 | — | — | US | disclosed |
| CN-1628088-A | Novel 3-aryl-2, 5-dihydroxy-1, 4-benzoquinones, process for preparing same and pharmaceutical compositions containing same | SERVIER LAB (FR) | 2005-06-15 | — | — | CN | disclosed |
| US-20050085644-A1 | Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same | LES LABORATOIRES SERVIER (FR) | 2005-04-21 | — | — | US | disclosed |
| EP-1472208-A1 | NOVEL 3-ARYL-2,5-DIHYDROXY-1,4-BENZOQUINONE DERIVATIVES, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2004-11-03 | — | — | EP | disclosed |
| CN-1525968-A | composition for preventing or treating liver disease | 三共株式会社 | 2004-09-01 | — | — | CN | disclosed |
| EP-0861864-B1 | Method of preparation of polyquinolines | HITACHI CHEMICAL CO LTD (JP) | 2004-08-25 | — | — | EP | disclosed |
| EP-1070711-B1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | SANKYO CO (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-20040054173-A1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| US-6667346-B2 | Administration of a radioprotective alpha, beta unsaturated aryl sulfone compound to a patient prior to anticancer radiotherapy reduces cytotoxic side effects of radiation on normal cells | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2003-12-23 | — | — | US | disclosed |
| EP-1352906-A1 | COMPOSITIONS FOR PREVENTION OR TREATMENT OF HEPATOPATHY | Sankyo Company, Limited (JP) | 2003-10-15 | — | — | EP | disclosed |
| WO-2003066561-A1 | NOVEL 3-ARYL-2,5-DIHYDROXY-1,4-BENZOQUINONE DERIVATIVES, THEIR PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2003-08-14 | — | — | WO | disclosed |
| EP-1074550-B1 | Process for the preparation of 3-substituted 4-phenyl-piperidine derivatives | CHEMI SPA (IT) | 2003-01-29 | — | — | EP | disclosed |
| EP-1243589-A1 | Heteroaryl-substituted pyrrole derivates, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 2002-09-25 | — | — | EP | disclosed |
| US-6444822-B1 | ANTIDEPRESSANTS | CHEMI S.P.A. (IT) | 2002-09-03 | — | — | US | disclosed |
| US-6306880-B1 | HETEROCYCLIC ALCOHOL DERIVATIVES AS FUNGICIDES | SANKYO COMPANY, LIMITED (JP) | 2001-10-23 | — | — | US | disclosed |
| US-20010031768-A1 | Triazole antifungal agent | SANKYO COMPANY LIMITED (JP) | 2001-10-18 | — | — | US | disclosed |
| US-20010031778-A1 | Triazole antifungal agent | SANKYO COMPANY LIMITED (JP) | 2001-10-18 | — | — | US | disclosed |
| US-6300357-B1 | FOR THERAPY OF MYCOTIC DISEASE OF A HUMAN BEING AND AN ANIMAL | SANKYO COMPANY, LIMITED (JP) | 2001-10-09 | — | — | US | disclosed |
| EP-0841327-B1 | TRIAZOLE ANTIFUNGAL AGENT | SANKYO CO (JP) | 2001-10-04 | — | — | EP | disclosed |
| CN-1295069-A | Heteraryl-substituted porrole derivatives, their prep. and therapeutic use | SANKYO CO (JP) | 2001-05-16 | — | — | CN | disclosed |
| EP-1074550-A1 | Process for the preparation of 3-substituted 4-phenyl-piperidine derivatives | CHEMI S.p.A. (IT) | 2001-02-07 | — | — | EP | disclosed |
| EP-1070711-A2 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-5977152-A | Triazole antifungal agent | SANKYO COMPANY, LIMITED (JP) | 1999-11-02 | — | — | US | disclosed |
| EP-0861864-A2 | Method of preparation of polyquinolines | HITACHI CHEMICAL CO., LTD. (JP) | 1998-09-02 | — | — | EP | disclosed |
| US-5786071-A | Method of preparation of polyquinolines | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| EP-0841327-A1 | TRIAZOLE ANTIFUNGAL AGENT | SANKYO COMPANY LIMITED (JP) | 1998-05-13 | — | — | EP | disclosed |
| US-5723573-A | ACETYLENIC END GROUPS | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1998-03-03 | — | — | US | disclosed |
| US-5648448-A | Method of preparation of polyquinolines | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1997-07-15 | — | — | US | disclosed |
| US-5508412-A | USED IN FORMATION OF UNSATURATED CYCLOHEXENONE OXIME ETHERS; HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-16 | — | — | US | disclosed |
| US-5407896-A | Herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1995-04-18 | — | — | US | disclosed |
| US-5403812-A | Also containing a sulfur-containing ring; control of grasses but selective of broad-leaved and monocotyledonous crops | BASF AKTIENGESELLSCHAFT (DE) | 1995-04-04 | — | — | US | disclosed |
| US-4880624-A | GUAIACOL, TRIMETHOXYBENZENE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1989-11-14 | — | — | US | disclosed |
| US-4282251-A | FUNGICIDES | SANDOZ LTD. (CH) | 1981-08-04 | — | — | US | disclosed |
| US-4160036-A | ADRENERGIC STIMULANTS | ALLEN & HANBURYS LIMITED (GB) | 1979-07-03 | — | — | US | disclosed |
| US-4012377-A | ANTIMICROBIAL, PARASITICIDES | GLAXO LABORATORIES LIMITED (EN) | 1977-03-15 | — | — | US | disclosed |
| US-4012377-A | ANTIMICROBIAL, PARASITICIDES | GLAXO LABORATORIES LIMITED (EN) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (37 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158638-A1 | PIPERIDINONE HERBICIDES | CYP1A1, CYP1B1, ARG1 | ALDH1A1 59/4885KDM4E 1751/4885MAPT 4336/4885 |
| US-10035800-B2 | Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors | BRD1, BRD3, BRD4 | ALDH1A1 332/4885KDM4E 938/4885MAPT 3305/4885 |
| US-20170247383-A1 | NEUROACTIVE COMPOUNDS AND METHODS OF USING THE SAME | GAP43, PNMT, SLC6A3 | ALDH1A1 281/4885KDM4E 2259/4885MAPT 807/4885 |
| US-20180298003-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | BRD3, BRD4, BRD1 | ALDH1A1 2163/4885KDM4E 1602/4885MAPT 1302/4885 |
| US-20200079784-A1 | Compounds, Compositions and Methods | BAX, CASP3, CASP8 | ALDH1A1 3491/4885KDM4E 4338/4885MAPT 1091/4885 |
| US-20230121698-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | ENPP1, ENPP3, PPA1 | ALDH1A1 2462/4885KDM4E 3548/4885MAPT 4401/4885 |
| US-20180353480-A1 | ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK1) | RIPK1, RIPK2, RIPK3 | ALDH1A1 4555/4885KDM4E 4151/4885MAPT 3759/4885 |
| US-20200291027-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | BRD3, BRD4, BRD1 | ALDH1A1 2163/4885KDM4E 1602/4885MAPT 1302/4885 |
| US-20210070756-A1 | TETRACYCLIC BROMODOMAIN INHIBITORS | BRD3, BRD4, BRD1 | ALDH1A1 2163/4885KDM4E 1602/4885MAPT 1302/4885 |
| US-20010031768-A1 | Triazole antifungal agent | ERG28, RIF1, NAT1 | ALDH1A1 1123/4885KDM4E 2229/4885MAPT 3625/4885 |
| US-10800790-B2 | Sesquiterpenoid STAT3 inhibitors | STAT3, JAK2, STAT6 | ALDH1A1 1903/4885KDM4E 2624/4885MAPT 4453/4885 |
| US-12043602-B2 | Fendiline derivatives | CYP11B2, CYP3A7, CYP4F2 | ALDH1A1 292/4885KDM4E 2954/4885MAPT 2791/4885 |
| US-20070037796-A1 | e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms | POLI, HRAS, CHUK | ALDH1A1 1956/4885KDM4E 2390/4885MAPT 4743/4885 |
| US-20160296499-A1 | Spiroindoline Antiparasitic Derivatives | PKD2, PKD1, AVPR2 | ALDH1A1 178/4885KDM4E 3461/4885MAPT 4482/4885 |
| US-20220024938-A1 | Compounds, Compositions and Methods | BAX, CASP3, CASP8 | ALDH1A1 3491/4885KDM4E 4338/4885MAPT 1091/4885 |
| US-20160214951-A1 | EBI2 MODULATORS | BIRC2, HAVCR2, MAVS | ALDH1A1 4277/4885KDM4E 1496/4885MAPT 3773/4885 |
| US-20060128756-A1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | IL2, IL1A, IL1B | ALDH1A1 871/4885KDM4E 4073/4885MAPT 4733/4885 |
| US-20220177440-A1 | Fendiline Derivatives | CYP11B2, CYP3A7, CYP4F2 | ALDH1A1 292/4885KDM4E 2954/4885MAPT 2791/4885 |
| US-20050283006-A1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | IL2, CNKSR1, IL1A | ALDH1A1 928/4885KDM4E 3407/4885MAPT 4699/4885 |
| US-10301318-B2 | Neuroactive compounds and methods of using the same | GAP43, PNMT, SLC6A3 | ALDH1A1 281/4885KDM4E 2259/4885MAPT 807/4885 |
| US-20050085644-A1 | Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same | GPR119, UGT1A1, UGT1A3 | ALDH1A1 329/4885KDM4E 2279/4885MAPT 4577/4885 |
| US-10709692-B2 | Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1) | RIPK1, RIPK2, RIPK3 | ALDH1A1 4555/4885KDM4E 4151/4885MAPT 3759/4885 |
| US-20150011620-A1 | ANTI-INVASIVE COMPOUNDS | MMP3, MMP10, MIF | ALDH1A1 2677/4885KDM4E 2604/4885MAPT 3571/4885 |
| US-10570129-B2 | Carboline antiparasitics | ADRA1D, DRD1, CHRM1 | ALDH1A1 381/4885KDM4E 3087/4885MAPT 4298/4885 |
| US-20150210640-A1 | 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE | RB1, F2, SFPQ | ALDH1A1 3043/4885KDM4E 688/4885MAPT 4798/4885 |
| US-11174262-B2 | Compounds, compositions and methods | BAX, CASP3, CASP8 | ALDH1A1 3491/4885KDM4E 4338/4885MAPT 1091/4885 |
| US-20170022218-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | F2, SERPINC1, F12 | ALDH1A1 414/4885KDM4E 3853/4885MAPT 4841/4885 |
| US-20160137663-A1 | NOVEL SESQUITERPENOID STAT3 INHIBITORS | STAT3, JAK2, STAT6 | ALDH1A1 2028/4885KDM4E 2666/4885MAPT 4358/4885 |
| US-20190337956-A1 | NEUROACTIVE COMPOUNDS AND METHODS OF USING SAME | GAP43, OPRL1, SLC6A3 | ALDH1A1 433/4885KDM4E 3916/4885MAPT 662/4885 |
| US-20040054173-A1 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | IL2, IL1B, IL1A | ALDH1A1 1023/4885KDM4E 3733/4885MAPT 4831/4885 |
| US-20250034121-A1 | COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS | GPR183, GPR180, GPR65 | ALDH1A1 4198/4885KDM4E 4149/4885MAPT 3530/4885 |
| US-20080312190-A1 | Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents | SUB1, CBR1, NAT1 | ALDH1A1 1560/4885KDM4E 3301/4885MAPT 4756/4885 |
| US-20010031778-A1 | Triazole antifungal agent | ERG28, NAT1, RIF1 | ALDH1A1 893/4885KDM4E 2992/4885MAPT 2797/4885 |
| US-20190315691-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE | CYP2D6, CYP2C19, CYP2B6 | ALDH1A1 605/4885KDM4E 875/4885MAPT 2870/4885 |
| US-20200031822-A1 | CARBOLINE ANTIPARASITICS | DRD1, ADRA1D, DRD2 | ALDH1A1 334/4885KDM4E 3549/4885MAPT 4336/4885 |
| US-11851433-B2 | Compounds, compositions and methods | BAX, CASP3, CASP8 | ALDH1A1 3491/4885KDM4E 4338/4885MAPT 1091/4885 |
| US-20090203747-A1 | NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE | NLN, NQO1, APP | ALDH1A1 625/4885KDM4E 2254/4885MAPT 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.